Voloridge Investment Management LLC lifted its stake in shares of CorVel Co. (NASDAQ:CRVL - Free Report) by 210.8% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 34,775 shares of the business services provider's stock after buying an additional 23,585 shares during the quarter. Voloridge Investment Management LLC owned about 0.07% of CorVel worth $3,869,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other large investors also recently modified their holdings of the company. Barclays PLC grew its holdings in shares of CorVel by 380.8% during the third quarter. Barclays PLC now owns 15,977 shares of the business services provider's stock worth $5,223,000 after purchasing an additional 12,654 shares in the last quarter. Nisa Investment Advisors LLC increased its position in CorVel by 217.1% during the 4th quarter. Nisa Investment Advisors LLC now owns 555 shares of the business services provider's stock valued at $62,000 after buying an additional 380 shares in the last quarter. SG Americas Securities LLC increased its holdings in shares of CorVel by 322.2% in the 4th quarter. SG Americas Securities LLC now owns 1,520 shares of the business services provider's stock worth $169,000 after purchasing an additional 1,160 shares in the last quarter. Inspire Investing LLC increased its holdings in shares of CorVel by 180.9% in the 4th quarter. Inspire Investing LLC now owns 3,570 shares of the business services provider's stock worth $397,000 after purchasing an additional 2,299 shares in the last quarter. Finally, Exchange Traded Concepts LLC boosted its stake in shares of CorVel by 216.7% in the 4th quarter. Exchange Traded Concepts LLC now owns 532 shares of the business services provider's stock worth $59,000 after buying an additional 364 shares during the last quarter. 51.36% of the stock is currently owned by institutional investors.
Insiders Place Their Bets
In other news, Director R Judd Jessup sold 935 shares of the stock in a transaction that occurred on Tuesday, May 27th. The shares were sold at an average price of $113.50, for a total value of $106,122.50. Following the completion of the sale, the director now owns 129,519 shares of the company's stock, valued at $14,700,406.50. This represents a 0.72% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Jeffrey J. Michael sold 16,523 shares of the stock in a transaction that occurred on Wednesday, April 9th. The stock was sold at an average price of $116.99, for a total transaction of $1,933,025.77. Following the transaction, the director now directly owns 551,787 shares of the company's stock, valued at $64,553,561.13. The trade was a 2.91% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 22,408 shares of company stock worth $2,597,264. Company insiders own 47.57% of the company's stock.
Wall Street Analyst Weigh In
Separately, Wall Street Zen raised CorVel from a "hold" rating to a "buy" rating in a research note on Friday, April 18th.
Get Our Latest Stock Report on CorVel
CorVel Stock Performance
CRVL traded up $0.97 during trading on Friday, hitting $111.70. 227,132 shares of the stock were exchanged, compared to its average volume of 120,027. The firm has a 50 day simple moving average of $112.21 and a 200 day simple moving average of $116.47. The firm has a market cap of $5.74 billion, a price-to-earnings ratio of 65.71 and a beta of 1.10. CorVel Co. has a 1 year low of $76.53 and a 1 year high of $128.61.
CorVel (NASDAQ:CRVL - Get Free Report) last posted its quarterly earnings data on Thursday, May 22nd. The business services provider reported $0.51 EPS for the quarter. CorVel had a net margin of 10.12% and a return on equity of 32.22%. The business had revenue of $231.51 million during the quarter.
About CorVel
(
Free Report)
CorVel Corporation provides workers' compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.
Further Reading
Before you consider CorVel, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CorVel wasn't on the list.
While CorVel currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
